Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ

Aug 22, 2016 - Christopher N. Luscombe, Josie Morrell, Simon Peace,* David Perez, Paul Rowland, Christopher J. Tame,. Sorif Uddin, Giovanni Vitulli, a...
0 downloads 0 Views 203KB Size
Addition/Correction pubs.acs.org/jmc

Correction to Evolution of a Novel, Orally Bioavailable Series of PI3Kδ Inhibitors from an Inhaled Lead for the Treatment of Respiratory Disease Augustin Amour, Nick Barton, Anthony W. J. Cooper, Graham Inglis, Craig Jamieson, Christopher N. Luscombe, Josie Morrell, Simon Peace,* David Perez, Paul Rowland, Christopher J. Tame, Sorif Uddin, Giovanni Vitulli, and Natalie Wellaway Journal of Medicinal Chemistry 2016, 59, 7239−7251. DOI:10.1021/acs.jmedchem.6b00799 Page 7239. In the listing of the authors, “Chris Tame” should be Christopher J. Tame, as indicated above.

© XXXX American Chemical Society

Page 7239. The abstract graphic requires a slightly modified version of the central structure. The correct abstract graphic is shown below.

A

DOI: 10.1021/acs.jmedchem.6b01157 J. Med. Chem. XXXX, XXX, XXX−XXX